Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Added

TDQS

A4.5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

With annotations already declaring readOnly, idempotent, and openWorld safety, the description adds substantial behavioral detail: type='company' pulls specific SEC EDGAR/XBRL fields (10-K revenue, net income, cash, long-term debt) with correct handling of off-calendar fiscal years; type='drug' pulls FAERS, FDA approval, and trial counts; results are sorted by primary metric; output includes paired data and citation URIs. This goes well beyond the annotation baseline.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense but well-organized, front-loading trigger phrases and immediately stating the tool's purpose. Every sentence carries meaningful detail (data sources, fiscal-year handling, sorting, citation URIs, efficiency claim). It's longer than ideal but earns its length given the tool's dual-type complexity. Slight reduction in verbiage could improve it, earning a 4 rather than a 5.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

The description covers the tool's function, input semantics, data-fetching behavior, output format (paired data + citation URIs), and sorting logic. It also sets expectations about scale (replaces 8–15 lookups). Without an output schema, it doesn't fully specify the response structure but does give enough for an agent to infer. Missing minor details like pagination or error cases, but for its complexity, it's largely complete.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3. The description adds valuable context beyond the schema: it explains what each type's data sources are (e.g., latest 10-K for company, FAERS/FDA/trials for drug), provides concrete examples like ["AAPL","MSFT"] and ["ozempic","mounjaro"], and clarifies that sorting is by primary metric. This enriches the meaning of both 'type' and 'values' significantly.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with explicit trigger phrases ("Compare X and Y") and defines the exact action: side-by-side comparison of 2–5 companies or drugs in one parallel call. It distinguishes itself from sibling tools by noting it replaces 8–15 sequential single-pack lookups, clearly positioning it as a batch comparison tool rather than a single-lookup entity_profile.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicit guidance is given: "ALWAYS PREFER over sequential single-pack lookups when comparing entities," along with concrete use cases (ranking, head-to-head, which is bigger). However, it doesn't name alternative sibling tools like entity_profile or search_within directly, only refers to them generically as "sequential single-pack lookups," leaving some ambiguity for an AI agent unfamiliar with the sibling list.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4/5.0
Disambiguation3/5

Some tools have distinct purposes (e.g., color tools, memory tools), but many data query tools (ask_pipeworx, ask_pipeworx_grounded, deep_research, entity_profile) overlap significantly, making it hard for an agent to choose the right one without deep knowledge of their nuances.

Naming Consistency4/5

Most tool names use snake_case with a verb_noun pattern (e.g., convert_color, identify_color, resolve_entity), but there is inconsistency in prefixes: some use 'ask_pipeworx', others 'pipeworx_', 'polymarket_', or 'scan_'. Overall, still readable and predictable.

Tool Count3/5

33 tools is on the high side for a single server, especially one named 'colorapi' which misleadingly suggests a focus on color only. The tool count is borderline appropriate for the actual broad data integration scope, but the mismatch with the server name is problematic.

Completeness4/5

The tool set covers a wide range of data sources and operations (SEC, FDA, patents, news, Polymarket, memory, subscriptions), with few obvious gaps. Minor lacks: no direct tool for updating stored memories or handling non-US companies, but overall comprehensive.